STRONGBRIDGE DUBLIN LIMITED
9Patents
9Active
9Granted
44Portfolio score
Filing activity: May 21, 2018 → Mar 21, 2022
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10517868B2 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions | Human Necessities | 6 | Active |
| US10835530B2 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions | Human Necessities | 5 | Active |
| US11020393B2 | Methods of treating disease with levoketoconazole | Human Necessities | 3 | Active |
| US11278547B2 | Methods of treating disease with levoketoconazole | Human Necessities | 2 | Active |
| US11903940B2 | Methods of treating disease with levoketoconazole | Human Necessities | 1 | Active |
| US12201632B2 | Levoketoconazole for treatment of congenital adrenal hyperplasia and primary aldosteronism | Human Necessities | 0 | Active |
| US11478471B2 | Methods and compositions for treating diabetes, metabolic syndrome and other conditions | Human Necessities | 0 | Active |
| US10398751B2 | Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use | Human Necessities | 0 | Active |
| US10987402B2 | Pharmaceutical compositions of water soluble peptides with poor solubility in isotonic conditions and methods for their use | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.